- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Asthma
- Meeting Date: May 2022
- Public Summary Document (PSD) March 2022 PBAC Meeting - (PDF 928KB)
- Public Summary Document (PSD) March 2022 PBAC Meeting - (Word 151KB)
Related Public Summary Documents
